Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03811132Completed

Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)

Role: lead

NCT04438018Completed

Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM

Role: lead

NCT03175315Not ApplicableCompleted

Evaluation of a Treatment and Education Program for Diabetic Patients Who Use Flash Glucose Monitoring

Role: lead

NCT02868931Not ApplicableCompleted

Evaluation of a Diabetes Treatment and Education Program for Insulin Pump Therapy (INPUT)

Role: lead

All 4 trials loaded